vs

Side-by-side financial comparison of ASGN Inc (ASGN) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.

ASGN Inc is the larger business by last-quarter revenue ($970.0M vs $617.8M, roughly 1.6× Hims & Hers Health, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs 0.6%, a 2.8% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -3.0%). ASGN Inc produced more free cash flow last quarter ($9.1M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -3.2%).

ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

ASGN vs HIMS — Head-to-Head

Bigger by revenue
ASGN
ASGN
1.6× larger
ASGN
$970.0M
$617.8M
HIMS
Growing faster (revenue YoY)
HIMS
HIMS
+31.4% gap
HIMS
28.4%
-3.0%
ASGN
Higher net margin
HIMS
HIMS
2.8% more per $
HIMS
3.3%
0.6%
ASGN
More free cash flow
ASGN
ASGN
$11.6M more FCF
ASGN
$9.1M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
-3.2%
ASGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASGN
ASGN
HIMS
HIMS
Revenue
$970.0M
$617.8M
Net Profit
$5.5M
$20.6M
Gross Margin
27.5%
71.9%
Operating Margin
2.9%
1.5%
Net Margin
0.6%
3.3%
Revenue YoY
-3.0%
28.4%
Net Profit YoY
-73.7%
-20.8%
EPS (diluted)
$0.13
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASGN
ASGN
HIMS
HIMS
Q1 26
$970.0M
Q4 25
$980.1M
$617.8M
Q3 25
$1.0B
$599.0M
Q2 25
$1.0B
$544.8M
Q1 25
$968.3M
$586.0M
Q4 24
$985.0M
$481.1M
Q3 24
$1.0B
$401.6M
Q2 24
$1.0B
$315.6M
Net Profit
ASGN
ASGN
HIMS
HIMS
Q1 26
$5.5M
Q4 25
$25.2M
$20.6M
Q3 25
$38.1M
$15.8M
Q2 25
$29.3M
$42.5M
Q1 25
$20.9M
$49.5M
Q4 24
$42.4M
$26.0M
Q3 24
$47.5M
$75.6M
Q2 24
$47.2M
$13.3M
Gross Margin
ASGN
ASGN
HIMS
HIMS
Q1 26
27.5%
Q4 25
28.9%
71.9%
Q3 25
29.4%
73.8%
Q2 25
28.7%
76.4%
Q1 25
28.4%
73.5%
Q4 24
29.0%
76.8%
Q3 24
29.1%
79.2%
Q2 24
29.1%
81.3%
Operating Margin
ASGN
ASGN
HIMS
HIMS
Q1 26
2.9%
Q4 25
5.7%
1.5%
Q3 25
6.7%
2.0%
Q2 25
5.8%
4.9%
Q1 25
4.8%
9.9%
Q4 24
7.5%
3.9%
Q3 24
7.7%
5.6%
Q2 24
7.8%
3.5%
Net Margin
ASGN
ASGN
HIMS
HIMS
Q1 26
0.6%
Q4 25
2.6%
3.3%
Q3 25
3.8%
2.6%
Q2 25
2.9%
7.8%
Q1 25
2.2%
8.4%
Q4 24
4.3%
5.4%
Q3 24
4.6%
18.8%
Q2 24
4.6%
4.2%
EPS (diluted)
ASGN
ASGN
HIMS
HIMS
Q1 26
$0.13
Q4 25
$0.58
$0.08
Q3 25
$0.87
$0.06
Q2 25
$0.67
$0.17
Q1 25
$0.48
$0.20
Q4 24
$0.94
$0.10
Q3 24
$1.06
$0.32
Q2 24
$1.02
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASGN
ASGN
HIMS
HIMS
Cash + ST InvestmentsLiquidity on hand
$143.6M
$228.6M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.8B
$540.9M
Total Assets
$4.0B
$2.2B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASGN
ASGN
HIMS
HIMS
Q1 26
$143.6M
Q4 25
$161.2M
$228.6M
Q3 25
$345.8M
Q2 25
$1.1B
Q1 25
$273.7M
Q4 24
$205.2M
$220.6M
Q3 24
$165.5M
Q2 24
$129.3M
Total Debt
ASGN
ASGN
HIMS
HIMS
Q1 26
$1.5B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
ASGN
ASGN
HIMS
HIMS
Q1 26
$1.8B
Q4 25
$1.8B
$540.9M
Q3 25
$1.8B
$581.0M
Q2 25
$1.8B
$562.7M
Q1 25
$1.8B
$549.3M
Q4 24
$1.8B
$476.7M
Q3 24
$1.8B
$440.1M
Q2 24
$1.8B
$362.0M
Total Assets
ASGN
ASGN
HIMS
HIMS
Q1 26
$4.0B
Q4 25
$3.7B
$2.2B
Q3 25
$3.7B
$2.2B
Q2 25
$3.7B
$1.9B
Q1 25
$3.7B
$891.7M
Q4 24
$3.4B
$707.5M
Q3 24
$3.4B
$602.3M
Q2 24
$3.5B
$480.5M
Debt / Equity
ASGN
ASGN
HIMS
HIMS
Q1 26
0.82×
Q4 25
0.65×
Q3 25
0.64×
Q2 25
0.66×
Q1 25
0.72×
Q4 24
0.58×
Q3 24
0.58×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASGN
ASGN
HIMS
HIMS
Operating Cash FlowLast quarter
$61.3M
Free Cash FlowOCF − Capex
$9.1M
$-2.5M
FCF MarginFCF / Revenue
0.9%
-0.4%
Capex IntensityCapex / Revenue
1.0%
10.3%
Cash ConversionOCF / Net Profit
2.98×
TTM Free Cash FlowTrailing 4 quarters
$290.6M
$57.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASGN
ASGN
HIMS
HIMS
Q1 26
Q4 25
$102.3M
$61.3M
Q3 25
$83.9M
$148.7M
Q2 25
$124.9M
$-19.1M
Q1 25
$16.8M
$109.1M
Q4 24
$100.2M
$86.4M
Q3 24
$135.8M
$85.3M
Q2 24
$90.7M
$53.6M
Free Cash Flow
ASGN
ASGN
HIMS
HIMS
Q1 26
$9.1M
Q4 25
$93.7M
$-2.5M
Q3 25
$72.0M
$79.3M
Q2 25
$115.8M
$-69.5M
Q1 25
$6.6M
$50.1M
Q4 24
$88.9M
$59.5M
Q3 24
$127.9M
$79.4M
Q2 24
$85.4M
$47.6M
FCF Margin
ASGN
ASGN
HIMS
HIMS
Q1 26
0.9%
Q4 25
9.6%
-0.4%
Q3 25
7.1%
13.2%
Q2 25
11.3%
-12.8%
Q1 25
0.7%
8.5%
Q4 24
9.0%
12.4%
Q3 24
12.4%
19.8%
Q2 24
8.3%
15.1%
Capex Intensity
ASGN
ASGN
HIMS
HIMS
Q1 26
1.0%
Q4 25
0.9%
10.3%
Q3 25
1.2%
11.6%
Q2 25
0.9%
9.3%
Q1 25
1.1%
10.1%
Q4 24
1.1%
5.6%
Q3 24
0.8%
1.5%
Q2 24
0.5%
1.9%
Cash Conversion
ASGN
ASGN
HIMS
HIMS
Q1 26
Q4 25
4.06×
2.98×
Q3 25
2.20×
9.43×
Q2 25
4.26×
-0.45×
Q1 25
0.80×
2.20×
Q4 24
2.36×
3.32×
Q3 24
2.86×
1.13×
Q2 24
1.92×
4.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons